{"id":987869,"date":"2026-07-31T07:05:11","date_gmt":"2026-07-31T11:05:11","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-august-investor-conferences\/"},"modified":"2026-07-31T07:05:11","modified_gmt":"2026-07-31T11:05:11","slug":"ocugen-to-participate-in-upcoming-august-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-august-investor-conferences\/","title":{"rendered":"Ocugen to Participate in Upcoming August Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>MALVERN, Pa., July  31, 2026  (GLOBE NEWSWIRE) &#8212; Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Company will present on its innovative modifier gene therapy platform at upcoming investor conferences in August 2026.<\/p>\n<p>\n        <strong><br \/>\n          <u>Oppenheimer 4<sup>th<\/sup><\/u><br \/>\n        <\/strong><br \/>\n        <strong><br \/>\n          <u>\u00a0Annual Biotech in the Berkshires Summit<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p>\n        <strong>Location:<\/strong> Miraval Resort, Lenox, MA<br \/><strong>Date:\u00a0<\/strong>Tuesday, August 4, 2026<br \/><strong>Time:\u00a0<\/strong>12:30\u20131:10 p.m. ET<br \/><strong>Session Title: <\/strong>Beyond the Readout: Building Durable Value in Rare Diseases &amp; Gen Meds<br \/><strong>Format:<\/strong> Panel discussion<br \/><strong>Panelists:\u00a0<\/strong>Shankar Musunuri, Pratik Shah, Ram Aiyar, Frank Gleeson, Allan Reine<br \/><strong>Moderators:\u00a0<\/strong>Leland Gershell, Managing Director, Senior Analyst, Biotechnology, Oppenheimer &amp; Co. Inc.; Kostas Biliouris, Managing Director, Senior Analyst, Biotechnology, Oppenheimer &amp; Co. Inc.<\/p>\n<p>\n        <strong><br \/>\n          <u>Canaccord 46<sup>th<\/sup><\/u><br \/>\n        <\/strong><br \/>\n        <strong><br \/>\n          <u>\u00a0Annual Growth Conference<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p>\n        <strong>Location:\u00a0<\/strong>Intercontinental Hotel (Dartmouth\/Eleanor Room), Boston, MA <br \/><strong>Date:\u00a0<\/strong>Tuesday, August 11, 2026<br \/><strong>Time: <\/strong>1:00\u20131:25 p.m. ET<br \/><strong>Format:<\/strong> Fireside chat<strong>\u00a0 <\/strong><br \/><strong>Presenter:\u00a0<\/strong>Dr. Shankar Musunuri, Chairman, CEO, and Co-Founder, Ocugen<\/p>\n<p>A webcast of the Canaccord presentation will be available under the \u201cEvents and Presentation\u201d page of the Investors section of the Company\u2019s website. A replay of the webcast will be available for 30 days following the event. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zMTy8BZsPoiUZ5VnZV6cKi48ogW4nD6fN17pgyAd00nbjlmo0LuBUSObQFHQqZ4x4EaNdKBM9332jb4aWzSeUSGa6RJW1TR3VOD9ptA9c1M=\" rel=\"nofollow\" target=\"_blank\">Investors | Ocugen, Inc<\/a>.<\/p>\n<p>\n        <strong>About Ocugen, Inc.<\/strong><br \/>\n        <br \/>Ocugen, Inc. is a pioneering biotechnology company developing gene therapies for blindness. The Company\u2019s breakthrough modifier gene therapy platform has the potential to address significant unmet medical needs across large patient populations through a gene-agnostic approach. Unlike traditional gene therapies and gene-editing technologies that target a single gene mutation, Ocugen\u2019s modifier gene therapies are designed to address the underlying disease biology by restoring balance across multiple gene networks. The Company is currently advancing programs for inherited retinal diseases and other causes of blindness that affect millions worldwide, including retinitis pigmentosa, Stargardt disease, and geographic atrophy, an advanced form of dry age-related macular degeneration. Discover more at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9RGausbsS9t8xfuVubQ0wejdu2xchOkWGhRooyfanV4xmO3eULOczwE7On8vXe39zboA4uN4fE_jhlNbF2seQg==\" rel=\"nofollow\" target=\"_blank\">www.ocugen.com<\/a> and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NqwIi_ebiWM4tIPuEXQMMvmXw2U-cN06kKXpX9pcnmQXe34g-6prspYj-5f5fMmTICus58MSuAOudVjG7E0TcOw-hxUe4auLGOxrKue_rSI=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hysxFeARDAUhrIJI13azKW2peVVoR4xSEyeIFCduSbzk0EkZsjRsEvTDz259U3Ar\" rel=\"nofollow\" target=\"_blank\">X<\/a>.<\/p>\n<p>\n        <strong>Cautionary Note on Forward-Looking Statements<\/strong><br \/>\n        <br \/>This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties. We may, in some cases, use terms such as \u201cpredicts,\u201d \u201cbelieves,\u201d \u201cpotential,\u201d \u201cproposed,\u201d \u201ccontinue,\u201d \u201cestimates,\u201d \u201canticipates,\u201d \u201cexpects,\u201d \u201cplans,\u201d \u201cintends,\u201d \u201cmay,\u201d \u201ccould,\u201d \u201cmight,\u201d \u201cwill,\u201d \u201cshould,\u201d or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. Such statements are subject to numerous important factors, risks, and uncertainties that may cause actual events or results to differ materially from our current expectations. These and other risks and uncertainties are more fully described in our periodic filings with the Securities and Exchange Commission (SEC), including the risk factors described in the section entitled \u201cRisk Factors\u201d in the quarterly and annual reports that we file with the SEC. Any forward-looking statements that we make in this press release speak only as of the date of this press release. Except as required by law, we assume no obligation to update forward-looking statements contained in this press release whether as a result of new information, future events, or otherwise, after the date of this press release.<\/p>\n<p>\n        <strong>Contact<\/strong>\n      <\/p>\n<p>Investors:<br \/>Candice Masse<br \/>astr partners <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SDgrqtSqGdsCivyT3kT25jPDhXt8Lu32mRrl3ayWnKoIABrscB1IepWgYv-brrOJgIBAxfZgvJrcrzvDke_sc5Hv7lfJZEr40DIntbvMd7irZrmIKMe0og0ss0Cy4XQP\" rel=\"nofollow\" target=\"_blank\">candice.masse@astrpartners.com<\/a><\/p>\n<p>Media: <br \/>Chris Clark <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QHBv3ixZHBmgf2u08qF2oGuANNZByxAxRspZ1qsEQZGpR1ZqPY94krcIY0tjDivUa2zxYijFCwP2aOj0CbvCXxNgjqO6nVivDYeBk3DeFsw=\" rel=\"nofollow\" target=\"_blank\">chris.clark@ocugen.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwMDk3NyM3NzUxMzM2IzIxODQ1MTk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MjJiNDhkNmUtMzNmNy00NWM2LTk1OWUtMmViYTdhNjdkN2UzLTExOTYwNzMtMjAyNi0wNy0zMS1lbg==\/tiny\/Ocugen.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MALVERN, Pa., July 31, 2026 (GLOBE NEWSWIRE) &#8212; Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Company will present on its innovative modifier gene therapy platform at upcoming investor conferences in August 2026. Oppenheimer 4th \u00a0Annual Biotech in the Berkshires Summit Location: Miraval Resort, Lenox, MADate:\u00a0Tuesday, August 4, 2026Time:\u00a012:30\u20131:10 p.m. ETSession Title: Beyond the Readout: Building Durable Value in Rare Diseases &amp; Gen MedsFormat: Panel discussionPanelists:\u00a0Shankar Musunuri, Pratik Shah, Ram Aiyar, Frank Gleeson, Allan ReineModerators:\u00a0Leland Gershell, Managing Director, Senior Analyst, Biotechnology, Oppenheimer &amp; Co. Inc.; Kostas Biliouris, Managing Director, Senior Analyst, Biotechnology, Oppenheimer &amp; Co. Inc. Canaccord 46th \u00a0Annual Growth Conference Location:\u00a0Intercontinental Hotel (Dartmouth\/Eleanor Room), Boston, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-august-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Ocugen to Participate in Upcoming August Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-987869","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ocugen to Participate in Upcoming August Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-august-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ocugen to Participate in Upcoming August Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MALVERN, Pa., July 31, 2026 (GLOBE NEWSWIRE) &#8212; Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Company will present on its innovative modifier gene therapy platform at upcoming investor conferences in August 2026. Oppenheimer 4th \u00a0Annual Biotech in the Berkshires Summit Location: Miraval Resort, Lenox, MADate:\u00a0Tuesday, August 4, 2026Time:\u00a012:30\u20131:10 p.m. ETSession Title: Beyond the Readout: Building Durable Value in Rare Diseases &amp; Gen MedsFormat: Panel discussionPanelists:\u00a0Shankar Musunuri, Pratik Shah, Ram Aiyar, Frank Gleeson, Allan ReineModerators:\u00a0Leland Gershell, Managing Director, Senior Analyst, Biotechnology, Oppenheimer &amp; Co. Inc.; Kostas Biliouris, Managing Director, Senior Analyst, Biotechnology, Oppenheimer &amp; Co. Inc. Canaccord 46th \u00a0Annual Growth Conference Location:\u00a0Intercontinental Hotel (Dartmouth\/Eleanor Room), Boston, &hellip; Continue reading &quot;Ocugen to Participate in Upcoming August Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-august-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-31T11:05:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwMDk3NyM3NzUxMzM2IzIxODQ1MTk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-august-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-august-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ocugen to Participate in Upcoming August Investor Conferences\",\"datePublished\":\"2026-07-31T11:05:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-august-investor-conferences\\\/\"},\"wordCount\":531,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-august-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwMDk3NyM3NzUxMzM2IzIxODQ1MTk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-august-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-august-investor-conferences\\\/\",\"name\":\"Ocugen to Participate in Upcoming August Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-august-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-august-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwMDk3NyM3NzUxMzM2IzIxODQ1MTk=\",\"datePublished\":\"2026-07-31T11:05:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-august-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-august-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-august-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwMDk3NyM3NzUxMzM2IzIxODQ1MTk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwMDk3NyM3NzUxMzM2IzIxODQ1MTk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-august-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ocugen to Participate in Upcoming August Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ocugen to Participate in Upcoming August Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-august-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Ocugen to Participate in Upcoming August Investor Conferences - Market Newsdesk","og_description":"MALVERN, Pa., July 31, 2026 (GLOBE NEWSWIRE) &#8212; Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Company will present on its innovative modifier gene therapy platform at upcoming investor conferences in August 2026. Oppenheimer 4th \u00a0Annual Biotech in the Berkshires Summit Location: Miraval Resort, Lenox, MADate:\u00a0Tuesday, August 4, 2026Time:\u00a012:30\u20131:10 p.m. ETSession Title: Beyond the Readout: Building Durable Value in Rare Diseases &amp; Gen MedsFormat: Panel discussionPanelists:\u00a0Shankar Musunuri, Pratik Shah, Ram Aiyar, Frank Gleeson, Allan ReineModerators:\u00a0Leland Gershell, Managing Director, Senior Analyst, Biotechnology, Oppenheimer &amp; Co. Inc.; Kostas Biliouris, Managing Director, Senior Analyst, Biotechnology, Oppenheimer &amp; Co. Inc. Canaccord 46th \u00a0Annual Growth Conference Location:\u00a0Intercontinental Hotel (Dartmouth\/Eleanor Room), Boston, &hellip; Continue reading \"Ocugen to Participate in Upcoming August Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-august-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-07-31T11:05:11+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwMDk3NyM3NzUxMzM2IzIxODQ1MTk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-august-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-august-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ocugen to Participate in Upcoming August Investor Conferences","datePublished":"2026-07-31T11:05:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-august-investor-conferences\/"},"wordCount":531,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-august-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwMDk3NyM3NzUxMzM2IzIxODQ1MTk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-august-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-august-investor-conferences\/","name":"Ocugen to Participate in Upcoming August Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-august-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-august-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwMDk3NyM3NzUxMzM2IzIxODQ1MTk=","datePublished":"2026-07-31T11:05:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-august-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-august-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-august-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwMDk3NyM3NzUxMzM2IzIxODQ1MTk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwMDk3NyM3NzUxMzM2IzIxODQ1MTk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-august-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ocugen to Participate in Upcoming August Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/987869","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=987869"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/987869\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=987869"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=987869"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=987869"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}